Rapid Elimination Of Npm1 Mutant Measurable Residual Disease (Mrd) Using Low Intensity Venetoclax-Based Combinations In Acute Myeloid Leukemia (Aml)

BLOOD(2019)

引用 4|浏览78
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要